Spink Katharine E.

CIK 00014571302 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001457130

Recent Transactions

45 trades

Award
Asterias Biotherapeutics, Inc.
Stock Option
2017-06-26+50,000→ 50,000 total
Tax Payment
Asterias Biotherapeutics, Inc.
Common Stock
2017-06-05$3.20/sh−7,260→ 10,949 total
Award
Asterias Biotherapeutics, Inc.
Stock Options
2017-03-30+150,000→ 150,000 total
Award
Asterias Biotherapeutics, Inc.
Common Stock
2017-03-30+18,209→ 18,209 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2017-01-09$4.60/sh−4,781→ 0 total
Tax Payment
Asterias Biotherapeutics, Inc.
Common Stock
2017-01-09−2,878→ 4,781 total
Exercise/Conversion
Asterias Biotherapeutics, Inc.
Options to Purchase Common Stock
2016-12-27+2,500→ 192,500 total
Exercise/Conversion
Asterias Biotherapeutics, Inc.
Common Stock
2016-12-27$2.34/sh+2,500→ 2,500 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2016-12-27$5.00/sh−2,500→ 0 total
Exercise/Conversion
Asterias Biotherapeutics, Inc.
Common Stock
2016-11-23$2.34/sh+2,500→ 2,500 total
Exercise/Conversion
Asterias Biotherapeutics, Inc.
Options to Purchase Common Stock
2016-11-23+2,500→ 195,000 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2016-11-23$5.41/sh−2,500→ 0 total
Exercise/Conversion
Asterias Biotherapeutics, Inc.
Common Stock
2016-11-17$2.34/sh+2,500→ 2,500 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2016-11-17$5.00/sh−2,500→ 0 total
Exercise/Conversion
Asterias Biotherapeutics, Inc.
Options to Purchase Common Stock
2016-11-17+2,500→ 197,500 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2016-10-06$4.11/sh−4,781→ 0 total
Tax Payment
Asterias Biotherapeutics, Inc.
Common Stock
2016-10-06−2,878→ 4,781 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2016-09-09$3.54/sh−9,608→ 0 total
Sale
Asterias Biotherapeutics, Inc.
Common Stock
2016-09-08$3.50/sh−9,728→ 9,608 total
Award
Asterias Biotherapeutics, Inc.
Restricted Stock Units
2016-03-25+30,635→ 30,635 total
Award
Asterias Biotherapeutics, Inc.
Stock Options (right to buy)
2016-02-28+165,000→ 165,000 total
Award
Asterias Biotherapeutics, Inc.
Stock Options (right to buy)
2015-11-04+100,000→ 100,000 total
Sale
Asterias Biotherapeutics, Inc.
Series A Common Stock
2015-09-15$6.00/sh−3,760→ 0 total
Tax Payment
Asterias Biotherapeutics, Inc.
Series A Common Stock
2015-06-30$4.60/sh−3,291→ 3,760 total
Award
Asterias Biotherapeutics, Inc.
Restricted Stock Units
2015-02-13+28,205→ 28,205 total
Award
Asterias Biotherapeutics, Inc.
Stock Option (right to buy)
2015-02-13+100,000→ 100,000 total
Sale
GERON CORP$GERN
Common Stock
2011-06-14$4.28/sh−22,591→ 328,561 total
Sale
GERON CORP$GERN
Common Stock
2011-05-24$4.47/sh−419→ 351,152 total
Award
GERON CORP$GERN
Common Stock
2011-05-20+5,000→ 346,571 total
Award
GERON CORP$GERN
Common Stock
2011-05-20+25,000→ 341,571 total
Award
GERON CORP$GERN
Employee Stock Option (right to buy)
2011-05-20+50,000→ 50,000 total
Award
GERON CORP$GERN
Common Stock
2010-07-09+35,000→ 226,571 total
Award
GERON CORP$GERN
Common Stock
2010-07-09+90,000→ 191,571 total
Award
GERON CORP$GERN
Common Stock
2010-07-09+90,000→ 316,571 total
Award
GERON CORP$GERN
Common Stock
2010-07-09+10,000→ 101,571 total
Sale
GERON CORP$GERN
Common Stock
2010-06-02$5.43/sh−8,186→ 91,571 total
Sale
GERON CORP$GERN
Common Stock
2010-05-24$5.11/sh−385→ 99,757 total
Award
GERON CORP$GERN
Common Stock
2010-05-19+25,000→ 100,142 total
Award
GERON CORP$GERN
Employee Stock Option (right to buy)
2010-05-19+50,000→ 50,000 total
Discretionary Transaction
GERON CORP$GERN
Common Stock
2010-01-14$6.22/sh+2,652→ 2,652 total
Award
GERON CORP$GERN
Common Stock
2009-05-29+25,000→ 35,142 total
Sale
GERON CORP$GERN
Common Stock
2009-05-29$6.35/sh−400→ 10,142 total
Award
GERON CORP$GERN
Common Stock
2009-05-29+40,000→ 75,142 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2009-05-29$6.52/sh+50,000→ 125,729 total
Sale
GERON CORP$GERN
Common Stock
2009-05-26$6.75/sh−2,864→ 10,542 total

Companies

Recent Filings

Address

C/O GERON CORPORATION 230 CONSTITUTION DRIVE

MENLO PARK, CA, 94025

View on SEC.gov